Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 2.01% to 1,834.05 Indian rupees Thursday, on what proved to be ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.79% to 1,761.80 Indian rupees Tuesday, on what proved to be an ...

Sun Pharmaceutical Industries Ltd is set to release its Q3 earnings for the quarter ending December 31, 2024, on Friday, January 31. The board will review and decide on the declaration of an ...

Drugmaker Sun Pharmaceutical Industries has inked an agreement with Zaza Industrial Holdings KK (Japan) to sell 100 per cent shares in its step-down subsidiary Sun Pharma Japan Technical ...

Pulak Sarmah has joined Sun Pharma as head of corporate marketing and brand. Prior to this role, Sarmah was working with Zurich Kotak General Insurance for the past 9 years. Advertisment He took ...

Drugmaker Sun Pharmaceutical Industries has entered into a definitive agreement to acquire 100% stake in Antibe Therapeutics Inc., an Ontario, Canada incorporated clinical-stage biotechnological ...

Pulak Sarmah has been appointed as Head of Corporate Brand Marketing at Sun Pharma. Prior to this, Pulak was associated with the Kotak Mahindra Group for 18 years, in marketing roles across ...

Sun Pharmaceuticals has developed a sizeable portfolio of speciality products that the company can now be seen as a speciality player. The existing speciality portfolio is powering earnings and ...

Stocks picks for 2025: M&M, Sun Pharma, and Dalmia Bharat are the top three stock picks by Sumeet Bagadia of Choice Broking for the new year with significant potential for long-term-based returns.( ...

Sun Pharmaceutical Industries share price gained in the early trade on January 1 after the company is going to sell its entire holding in Japanese subsidiary. At 09:26am, Sun Pharmaceutical ...

Thus, it is expected that the stock may see a price target of Rs. 4270 in 8 to 10 months. Sun Pharma has been maintaining its bullish momentum as prices are seen holding well above its 200-DEMA on ...

Vibha Shanghvi, wife of Dilip Shanghvi, chairman and managing director of Sun Pharma has purchased two apartments worth ₹130 crore in Mumbai's Worli area. (Representational Photo)(Raju Shinde/HT ...